Keenova Therapeutics plc announced today that the first patient has been successfully enrolled and received study treatment in its Phase 3 clinical trial evaluating XIAFLEX® (collagenase clostridium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results